|
LDR
| 01596nam a22004575i 4500 |
|---|
| 001 | 5009 |
|---|
| 003 | CONS |
|---|
| 005 | 20121024164225.0 |
|---|
| 007 | cr nn 008mamaa |
|---|
| 008 | 110621s2011 gw | s |||| 0|eng d |
|---|
| 020 | | . |
‡a9783642179693
‡9978-3-642-17969-3 |
|---|
| 024 | 7 | . |
‡a10.1007/978-3-642-17969-3
‡2doi |
|---|
| 035 | | . |
‡a(DE-He213)978-3-642-17969-3 |
|---|
| 050 | | 4. |
‡aRM1-950 |
|---|
| 072 | | 7. |
‡aMMG
‡2bicssc |
|---|
| 072 | | 7. |
‡aMED071000
‡2bisacsh |
|---|
| 100 | 1 | . |
‡aFrancis, Sharron H. |
|---|
| 245 | 1 | 0. |
‡aPhosphodiesterases as Drug Targets
‡h[electronic resource] /
‡cedited by Sharron H. Francis, Marco Conti, Miles D. Houslay. |
|---|
| 260 | | . |
‡aBerlin, Heidelberg :
‡bSpringer Berlin Heidelberg,
‡c2011. |
|---|
| 300 | | . |
‡aXVII, 519p. 78 illus., 21 illus. in color.
‡bdigital. |
|---|
| 490 | 0 | . |
‡aHandbook of Experimental Pharmacology,
‡x0171-2004 ;
‡v204 |
|---|
| 650 | | 0. |
‡aMedicine. |
|---|
| 650 | | 0. |
‡aToxicology. |
|---|
| 650 | | 0. |
‡aBiochemistry. |
|---|
| 650 | | 0. |
‡aEnzymes. |
|---|
| 650 | | 0. |
‡aPost-translational modification of proteins. |
|---|
| 650 | | 0. |
‡aCytology. |
|---|
| 650 | 1 | 4. |
‡aBiomedicine. |
|---|
| 650 | 2 | 4. |
‡aPharmacology/Toxicology. |
|---|
| 650 | 2 | 4. |
‡aMedicinal Chemistry. |
|---|
| 650 | 2 | 4. |
‡aProtein Structure. |
|---|
| 650 | 2 | 4. |
‡aEnzymology. |
|---|
| 650 | 2 | 4. |
‡aPosttranslational Modification. |
|---|
| 650 | 2 | 4. |
‡aCell Physiology. |
|---|
| 700 | 1 | . |
‡aConti, Marco. |
|---|
| 700 | 1 | . |
‡aHouslay, Miles D. |
|---|
| 710 | 2 | . |
‡aSpringerLink (Online service) |
|---|
| 773 | 0 | . |
‡tSpringer eBooks |
|---|
| 776 | 0 | 8. |
‡iPrinted edition:
‡z9783642179686 |
|---|
| 830 | | 0. |
‡aHandbook of Experimental Pharmacology,
‡x0171-2004 ;
‡v204 |
|---|
| 856 | 4 | 0. |
‡uhttp://dx.doi.org/10.1007/978-3-642-17969-3
‡9CONS |
|---|
| 950 | | . |
‡aBiomedical and Life Sciences (Springer-11642) |
|---|
| 901 | | . |
‡a5009
‡b
‡c5009
‡tbiblio
‡sSystem Local |
|---|
E-book
